Skip to main content

WIXELA INHUB

ICSLABA DPI

Fluticasone propionate / Salmeterol · Viatris (Mylan)

Clinical Reference · Data reviewed June 2026

Active Medication & Mechanism

  • Fluticasone propionate ICS
    100 mcg, 250 mcg, or 500 mcg per blister

    Synthetic corticosteroid with potent anti-inflammatory activity. Inhibits inflammatory cells and mediators involved in airway inflammation.

  • Salmeterol xinafoate LABA
    50 mcg per blister

    Long-acting beta2-adrenergic agonist. Provides prolonged bronchodilation (≥12 hours) via beta2-receptor stimulation.

FDA-Approved Dosing — Strength × Indication

100/50 mcg 1 inhalation twice daily (~12 hours apart) → 200/100 mcg
Asthma FDA Approved
Generic substitution for Advair Diskus 100/50. For patients not controlled on ICS or whose disease warrants ICS/LABA.
COPD Not Approved
100/50 is NOT indicated for COPD.
250/50 mcg 1 inhalation twice daily → 500/100 mcg
Asthma FDA Approved
Generic substitution for Advair Diskus 250/50.
COPD FDA Approved
Maintenance of airflow obstruction in COPD. Only the 250/50 strength is approved for COPD.
500/50 mcg 1 inhalation twice daily → 1000/100 mcg
Asthma FDA Approved
Generic substitution for Advair Diskus 500/50.
COPD Not Approved
500/50 is NOT indicated for COPD.

All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling

Not a rescue inhaler. Not for acute use. Use a SABA.

Related Inhalers

For educational reference by healthcare professionals. Not medical advice and not for use in clinical decision-making. This workspace is not a substitute for clinical judgement, prescribing information, or product monographs — always verify doses and indications against the most current labelling. If you are a patient, do not use this site to make medication decisions — speak with your clinician.

Device images are original illustrations for identification aid only — actual devices and packaging may differ. This site is not affiliated with or endorsed by any pharmaceutical manufacturer. Clinical data last reviewed: June 2026.

Inhaler Database · © inhalerdatabase.com 2024–2026 — All rights reserved